MBX Biosciences, Inc. (MBX) Stock Statistics & Valuation Metrics

MBX Biosciences, Inc. has a market cap or net worth of $382.88M. The enterprise value is ―.

MBX Biosciences, Inc. has 33,424,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

MBX Biosciences, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -26.48%.

The current PE Ratio of MBX Biosciences, Inc. is -9.94. MBX Biosciences, Inc.’s PEG ratio is 0.46.

In the last 12 months, MBX Biosciences, Inc. had revenue of 0.00 and earned -61.92M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -30.70M and capital expenditures -149.00K, giving a free cash flow of -30.85M billion.

MBX Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MBX Biosciences, Inc. upcoming earnings date is May 12, 2025, TBA Not Confirmed.

MBX Biosciences, Inc. as a current ratio of 24.19, with Debt / Equity ratio of 0.07%

In the past 12 months, MBX Biosciences, Inc. has paid 0.00 in taxes.

MBX Biosciences, Inc. EV to EBITDA ratio is -8.33, with an EV/FCF ratio of -10.19.

MBX Biosciences, Inc. has $262.15M in cash and marketable securities with $171.00K in debt, giving a net cash position of -$261.98M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MBX Biosciences, Inc. is $39.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy